ASIDE FROM THOSE INCORPORATED IN THE GUIDELINES OF ONCOLOGY PRACTICE
1.EGFR
2.ALK
Now we are hearing about the following
1.ROS-1
2.MEK-1
3.RET
4.BRAF
5.HER-2
6.PI3KCA
7.KRAS
8.PD-1,2
9.ERCC1
10.BRCA-1 mRNA
11 P53
What about the therapeutic roles of :
GSTM-1 and GSTT1,FAK, Wnt, Notch, p16,
HIF and VGEF and the CYP1A1,P ?
A blog about research, awareness, prevention, treatment and survivorship of Breast Cancer and all cancers, including targeted scientific research and a grassroots approach to increase screening for cancer, especially in the low income and under-insured population of El Paso, Texas, with a view to expand this new health care model to many other 'minority' populations across the United States and beyond
Showing posts with label GSTM-1. Show all posts
Showing posts with label GSTM-1. Show all posts
Thursday, November 14, 2013
NEW GENES ARE BEING INCLUDED IN THE CLINICAL THERAPY OF LUNG CANCERS!
Labels:
16,
BRCA-1 mRNA,
crbcm,
CYP1A1,
ERCC1,
FAK,
GSTM-1,
GSTT1,
HIF,
kankonde,
KRAS,
lung cancer,
notch,
P53,
PI3KCA,
VGEF,
Wnt
Subscribe to:
Posts (Atom)